FILE:JNJ/JNJ-8K-20060309150022.txt.gz
EVENTS:	Other Events
TEXT:
ITEM: Other Events
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 8,2006 JOHNSON & JOHNSON (Exact name of registrant as specified in its charter) New Jersey 1-3215 22-1024240 (State or Other Juris- (Commission (IRS Employer diction of Incorporation) File Number) Identification No.) One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: 732-524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 8.01. Other Events. On March 8, 2006, Johnson & Johnson (the "Company") announced that its Board of Directors has approved a stock repurchase program, authorizing the Company to buy back up to $5 billion of the Company's common stock. The Company issued a press release on March 8, 2006, which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. (c) Exhibits. 99.1 Press release dated March 8, 2006. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JOHNSON & JOHNSON (Registrant) Date: March 9, 2006 By: /s/ Michael H. Ullmann Michael H. Ullmann Secretary EXHIBIT INDEX Exhibit No. Description 99.1 Press release dated March 8, 2006.

Exhibit 99.1 Press Contact: Jeffrey J. Leebaw (732) 524-3350 Investor Contacts: Louise Mehrotra Stan Panasewicz (732) 524-6491 (732) 524-2524 FOR IMMEDIATE RELEASE Johnson & Johnson Announces Stock Repurchase Program New Brunswick, NJ (March 8, 2006) - Johnson & Johnson today announced that its Board of Directors has approved a stock repurchase program, authorizing the Company to buy back up to $5 billion of the corporation's common stock. Repurchases will take place on the open market from time to time based on market conditions. The repurchase program has no time limit and may be suspended for periods or discontinued. Johnson & Johnson's adjusted average shares outstanding at year-end 2005 were 3,012.5 million on a diluted basis. Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 200 Johnson & Johnson operating companies employ approximately 115,600 men and women in 57 countries and sell products throughout the world. ###


